Clinical Trial Update: Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study [Phase 2]

View source ↗

Summary

Phase 2 gastric adenocarcinoma study evaluating whether genetic polymorphisms can predict treatment efficacy and toxicity; the trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Gastric Adenocarcinoma | Phase 2 | Status: TERMINATED